CRNX vs KYMR
Crinetics Pharmaceuticals, Inc. · Kymera Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | CRNX | KYMR |
|---|---|---|
| Price | $84.95 | $117.39 |
| Market Cap | $9.01B | $9.76B |
| P/E | — | — |
| P/B | 7.56 | 6.47 |
| P/S | 1170.77 | 248.94 |
| ROE | -39.0% | -20.6% |
| Net Margin | -6046.2% | -794.0% |
| Gross Margin | — | — |
| Revenue Growth | 640.7% | -16.7% |
| Dividend Yield | — | — |
| EPS | -$4.39 | -$3.74 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.